Reirradiation for Recurrent Meningioma

Purpose/Objective(s): Management options for meningioma include observation, surgical resection, and radiation therapy (RT). In cases of progressive or recurrent disease after RT, similar options exist. The control rate following a second course of RT is unknown. American Society for Therapeutic Radiation Oncology (ASTRO) 52nd Annual Meeting October 31 - November 4, San Diego, C

Dosimetric validation of a magnetic resonance image gated radiotherapy system using a motion phantom and radiochromic film.

PurposeMagnetic resonance image (MRI) guided radiotherapy enables gating directly on the target position. We present an evaluation of an MRI-guided radiotherapy system's gating performance using an MRI-compatible respiratory motion phantom and radiochromic film. Our evaluation is geared toward validation of our institution's clinical gating protocol which involves planning to a target volume formed by expanding 5 mm about the gross tumor volume (GTV) and gating based on a 3 mm window about the GTV.MethodsThe motion phantom consisted of a target rod containing high-contrast target inserts which moved in the superior-inferior direction inside a body structure containing background contrast material. The target rod was equipped with a radiochromic film insert. Treatment plans were generated for a 3 cm diameter spherical planning target volume, and delivered to the phantom at rest and in motion with and without gating. Both sinusoidal trajectories and tumor trajectories measured during MRI-guided treatments were used. Similarity of the gated dose distribution to the planned, motion-frozen, distribution was quantified using the gamma technique.ResultsWithout gating, gamma pass rates using 4%/3 mm criteria were 22-59% depending on motion trajectory. Using our clinical standard of repeated breath holds and a gating window of 3 mm with 10% target allowed outside the gating boundary, the gamma pass rate was 97.8% with 3%/3 mm gamma criteria. Using a 3 mm window and 10% allowed excursion, all of the patient tumor motion trajectories at actual speed resulting in at least 95% gamma pass rate at 4%/3 mm.ConclusionsOur results suggest that the device can be used to compensate respiratory motion using a 3 mm gating margin and 10% allowed excursion results in conjunction with repeated breath holds. Full clinical validation requires a comprehensive evaluation of tracking performance in actual patient images, outside the scope of this study

RUBinform

In dieser Ausgabe: ▪ Schwachstelle Mensch ▪ E-Mail Spoofing ▪ Informationssicherheit an der RUB ▪ Server sicher verorten ▪ Postkarte oder Einschreiben

RUBinform

In dieser Ausgabe: ▪ Netzwerkdrucker - die unterschätzte Gefahr ▪ Stromausfall - und jetzt? ▪ Countdown ▪ USB Attacken ▪ Informatives für Administratoren ▪ BITS: Urheberrechtsgesetz § 52

RUBinform

In dieser Ausgabe: ▪ European Cyber Security Month ▪ Das Märchen vom Datacenter ▪ "Diese Seite verwendet Cookies..." ▪ Interim für die IT ▪ Die RUB und die DS-GV

RUBinform

In dieser Ausgabe: ▪ Alles Emotet? - Untergründiges ▪ Zeit aufzuräumen ▪ Die clevere Alternative: Etherpad ▪ Das neue RUB-Datacenter ▪ Virus trifft Viru

RUBinform

In dieser Ausgabe: ▪ Gesetz über das Urheberrecht ▪ Neue Regelungen für Bibliotheken ▪ Rechtliche Aspekte im Forschungsdatenmanagement ▪ Umgang mit Fotos in Frage gestellt? ▪ Schranken für Forschung, Lehre und Private

RUBinform

In dieser Ausgabe: ▪ Wie kann ich da sicher sein? ▪ Märchen werden manchmal wahr ▪ Das smarte Zuhause ▪ Die clevere Alternative: Sciebo ▪ Firefox-Addon